"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","48/81","481/2914",9.71385671386093e-19,5.93516645216903e-16,3.13910948542664e-16,"AKT1/AKT2/AKT3/CSNK2A1/CTNNB1/HDAC1/HDAC2/HDAC3/PML/PPARGC1A/PPP2CA/PPP2CB/PRKACA/SP1/TP53/CREBBP/CSNK2A2/FBXW7/RB1/AR/CDK1/E2F1/EP300/GSK3B/MAF/MAPK14/STAT1/STK11/UBE2I/YWHAQ/YWHAZ/MAPK1/MAPK3/NR3C1/SMAD3/TWIST1/YY1/TCF7L2/SOX2/ESRRA/BCL6/MYB/SMAD4/TBP/FOS/SREBF1/HNF4A/MEF2C",48
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","48/81","499/2914",4.87924177140369e-18,1.49060836116383e-15,7.88382749379439e-16,"AKT1/AKT2/AKT3/CSNK2A1/CTNNB1/HDAC1/HDAC2/HDAC3/PML/PPARGC1A/PPP2CA/PPP2CB/PRKACA/SP1/TP53/CREBBP/CSNK2A2/FBXW7/RB1/AR/CDK1/E2F1/EP300/GSK3B/MAF/MAPK14/STAT1/STK11/UBE2I/YWHAQ/YWHAZ/MAPK1/MAPK3/NR3C1/SMAD3/TWIST1/YY1/TCF7L2/SOX2/ESRRA/BCL6/MYB/SMAD4/TBP/FOS/SREBF1/HNF4A/MEF2C",48
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","18/81","62/2914",9.87885701709843e-15,2.01199387914905e-12,1.0641435453506e-12,"AKT1/AKT2/AKT3/HDAC3/PPARGC1A/FBXW7/RB1/AR/CDK1/GSK3B/MAF/STAT1/MAPK1/MAPK3/NR3C1/TWIST1/ESRRA/SMAD4",18
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","16/81","49/2914",4.47456395149387e-14,6.83489643590688e-12,3.61497666607531e-12,"AKT1/AKT2/AKT3/HDAC1/HDAC2/PPARGC1A/CREBBP/EP300/STK11/YWHAQ/YWHAZ/NR3C1/SMAD3/BCL6/SMAD4/SREBF1",16
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","13/81","30/2914",1.80967603646552e-13,2.21142411656087e-11,1.16962219619982e-11,"MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/FOS/MEF2C",13
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","37/81","397/2914",1.04911961109755e-12,1.06835347063434e-10,5.65052141415699e-11,"AKT1/AKT2/AKT3/CSNK2A1/CTNNB1/HDAC3/PAK1/PML/PPARGC1A/PRKACA/RPS6KA1/RPS6KA2/RPS6KA4/RPS6KA5/CREBBP/CSNK2A2/RELA/E2F1/EP300/GSK3B/MAPK14/PIK3CA/PIK3R1/STAT3/MAPK1/MAPK3/NR2F2/SMAD3/YY1/SOX2/FLI1/NFKB1/MYB/SMAD4/SREBF1/HNF4A/MEF2C",37
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","11/81","24/2914",7.15460962032706e-12,6.24495211145691e-10,3.3029551179555e-10,"PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/MEF2C",11
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","16/81","78/2914",1.22902727323104e-10,7.50935663944166e-09,3.97169866191505e-09,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","16/81","78/2914",1.22902727323104e-10,7.50935663944166e-09,3.97169866191505e-09,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","16/81","78/2914",1.22902727323104e-10,7.50935663944166e-09,3.97169866191505e-09,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-450294","R-HSA-450294","MAP kinase activation","14/81","60/2914",3.26217241897429e-10,1.68807481326133e-08,8.92822754192831e-09,"MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",14
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","16/81","83/2914",3.31536788201898e-10,1.68807481326133e-08,8.92822754192831e-09,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","16/81","84/2914",4.0075692716943e-10,1.74901773214659e-08,9.25055463466279e-09,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","16/81","84/2914",4.0075692716943e-10,1.74901773214659e-08,9.25055463466279e-09,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","16/81","86/2914",5.80767569024613e-10,2.02608337570115e-08,1.07159547995564e-08,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","16/81","86/2914",5.80767569024613e-10,2.02608337570115e-08,1.07159547995564e-08,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","16/81","86/2914",5.80767569024613e-10,2.02608337570115e-08,1.07159547995564e-08,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","8/81","14/2914",6.60483557319825e-10,2.02608337570115e-08,1.07159547995564e-08,"AKT1/AKT2/AKT3/HDAC1/HDAC2/PML/TP53/EP300",8
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","16/81","87/2914",6.96362535020035e-10,2.02608337570115e-08,1.07159547995564e-08,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","16/81","87/2914",6.96362535020035e-10,2.02608337570115e-08,1.07159547995564e-08,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","16/81","87/2914",6.96362535020035e-10,2.02608337570115e-08,1.07159547995564e-08,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","14/81","64/2914",8.24093701430137e-10,2.28873296169915e-08,1.21051084372752e-08,"MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",14
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","16/81","90/2914",1.18240523402946e-09,3.01020665830001e-08,1.59209827564493e-08,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","16/81","90/2914",1.18240523402946e-09,3.01020665830001e-08,1.59209827564493e-08,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","9/81","21/2914",1.41842876161584e-09,3.46663989338912e-08,1.83350580975185e-08,"PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/MAPK14/MAPK1/MAPK3/MEF2C",9
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","22/81","187/2914",2.29810769174992e-09,5.40055307561232e-08,2.85635247517096e-08,"MAPK9/RPS6KA1/RPS6KA2/SP1/TP53/CREBBP/RB1/RELA/AR/E2F1/EP300/GSK3B/MAP3K5/MAPK14/STAT3/MAPK1/MAPK3/MAPKAPK2/NR3C1/ARNT/NFKB1/FOS",22
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","16/81","95/2914",2.72668893929472e-09,6.14260317807712e-08,3.24882276797257e-08,"AKT1/AKT2/AKT3/CSNK2A1/HDAC1/HDAC2/PML/PPP2CA/PPP2CB/TP53/CSNK2A2/CDK1/EP300/MAPK14/STK11/TBP",16
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","22/81","189/2914",2.82612459873657e-09,6.14260317807712e-08,3.24882276797257e-08,"MAPK9/RPS6KA1/RPS6KA2/SP1/TP53/CREBBP/RB1/RELA/AR/E2F1/EP300/GSK3B/MAP3K5/MAPK14/STAT3/MAPK1/MAPK3/MAPKAPK2/NR3C1/ARNT/NFKB1/FOS",22
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","14/81","70/2914",2.91547450350633e-09,6.14260317807712e-08,3.24882276797257e-08,"PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/MAPK14/PIK3CA/PIK3R1/STAT3/MAPK1/MAPK3/MAPKAPK2/ATF1/MEF2C",14
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","29/81","332/2914",4.32956270898911e-09,8.81787605064115e-08,4.66377456722686e-08,"AKT1/HMGB1/MAPK9/PPP2CA/PPP2CB/PRKACA/RPS6KA1/RPS6KA2/RPS6KA5/TP53/RELA/JAK2/MAPK14/PIK3CA/PIK3R1/STAT1/STAT3/YWHAZ/MAPK1/MAPK3/MAPKAPK2/SMAD3/ATF1/TWIST1/SOX2/NFKB1/BCL6/FOS/MEF2C",29
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","22/81","194/2914",4.68260729441857e-09,9.2292679254508e-08,4.88135972626995e-08,"AKT1/AKT2/AKT3/CSNK2A1/HDAC1/HDAC2/PML/PPP2CA/PPP2CB/TP53/CREBBP/CSNK2A2/CDK1/E2F1/EP300/MAPK14/STK11/YWHAQ/YWHAZ/BCL6/TBP/FOS",22
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","16/81","99/2914",5.11996142168441e-09,9.77592633952868e-08,5.17048735676683e-08,"MAPK9/RPS6KA1/RPS6KA2/SP1/TP53/RB1/RELA/E2F1/MAP3K5/MAPK14/STAT3/MAPK1/MAPK3/MAPKAPK2/NFKB1/FOS",16
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","18/81","136/2914",1.3497725189313e-08,2.49912426990008e-07,1.32178680482268e-07,"AKT1/AKT2/AKT3/HDAC1/HDAC3/SP1/CREBBP/EP300/PIK3CA/PIK3R1/PRKCZ/MAPK1/MAPK3/YY1/MYB/TBP/FOS/SREBF1",18
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","16/81","108/2914",1.89455054645845e-08,3.40461877613562e-07,1.80070284137072e-07,"AKT1/AKT2/AKT3/HDAC1/SP1/CREBBP/EP300/PIK3CA/PIK3R1/PRKCZ/MAPK1/MAPK3/YY1/MYB/TBP/FOS",16
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","16/81","110/2914",2.48746985100179e-08,4.34241165417741e-07,2.29670148648887e-07,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","12/81","59/2914",3.63100464524508e-08,6.16262177290207e-07,3.25941060260304e-07,"AKT1/AKT2/AKT3/CSNK2A1/HDAC1/HDAC2/HDAC3/PML/TP53/CSNK2A2/MAPK1/MAPK3",12
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","14/81","89/2914",7.56515835639855e-08,1.24927344750257e-06,6.60740715622861e-07,"PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/MAPK14/PIK3CA/PIK3R1/STAT3/MAPK1/MAPK3/MAPKAPK2/ATF1/MEF2C",14
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","24/81","268/2914",9.28477481523654e-08,1.4928940558183e-06,7.89591653262498e-07,"AKT1/AKT2/AKT3/CTNNB1/HDAC1/HDAC2/HDAC3/PPP2CA/PPP2CB/CREBBP/FBXW7/EP300/GSK3B/JAK2/PIK3CA/PIK3R1/STAT1/STAT3/MAPK1/MAPK3/SMAD3/TCF7L2/SMAD4/CUX1",24
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","16/81","127/2914",2.00648507034243e-07,3.14349327686981e-06,1.66259356705837e-06,"HMGB1/MAPK9/PPP2CA/PPP2CB/RPS6KA1/RPS6KA2/RPS6KA5/RELA/MAPK14/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",16
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","7/81","19/2914",3.80489488864353e-07,5.67022140722243e-06,2.99898005343662e-06,"PAK1/PRKACA/RPS6KA5/CREBBP/RELA/EP300/NFKB1",7
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","7/81","19/2914",3.80489488864353e-07,5.67022140722243e-06,2.99898005343662e-06,"HDAC1/HDAC2/PPARGC1A/NR3C1/SMAD3/SMAD4/SREBF1",7
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","22/81","249/2914",4.76920448992982e-07,6.93805700796933e-06,3.66953829175051e-06,"AKT1/AKT2/AKT3/CSNK2A1/HDAC1/PPP2CA/PPP2CB/PRKACA/SET/TP53/CSNK2A2/RB1/CDK1/E2F1/EP300/GSK3B/JAK2/UBE2I/YWHAQ/YWHAZ/MAPK1/MAPK3",22
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","15/81","119/2914",5.08545138392418e-07,7.2260716176225e-06,3.82186921631512e-06,"CSNK2A1/HDAC3/PPARGC1A/PRKACA/SP1/CREBBP/CSNK2A2/EP300/PIK3CA/PIK3R1/UBE2I/MAPKAPK2/ARNT/ESRRA/SREBF1",15
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","10/81","49/2914",5.35265851553125e-07,7.43289625679453e-06,3.93125876619161e-06,"AKT1/AKT2/AKT3/TP53/E2F1/STAT3/YWHAQ/YWHAZ/MAPK1/MAPK3",10
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","19/81","191/2914",5.57116561111749e-07,7.56440486309508e-06,4.00081366693116e-06,"AKT1/AKT2/AKT3/CSNK2A1/HDAC1/PPP2CA/PPP2CB/PRKACA/SET/TP53/CSNK2A2/RB1/CDK1/E2F1/EP300/GSK3B/JAK2/MAPK1/MAPK3",19
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","14/81","108/2914",9.08486869384008e-07,1.20670755911658e-05,6.38227617622175e-06,"AKT1/AKT2/CSNK2A1/CTNNB1/HDAC1/PPP2CA/PPP2CB/CREBBP/CSNK2A2/EP300/GSK3B/YWHAZ/TCF7L2/SOX2",14
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","9/81","44/2914",2.03454554431432e-06,2.64490920760861e-05,1.39889245712093e-05,"MAPK9/TP53/E2F1/MAP3K5/MAPK14/MAPK1/MAPK3/MAPKAPK2/FOS",9
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","7/81","24/2914",2.33537253206375e-06,2.97273461893949e-05,1.57227931434994e-05,"HDAC3/RB1/AR/MAF/MAPK1/MAPK3/SMAD4",7
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","17/81","172/2914",2.71672965003178e-06,3.38759554320289e-05,1.79169925361924e-05,"AKT1/AKT2/AKT3/CSNK2A1/HDAC1/HDAC2/HDAC3/PML/PPP2CA/PPP2CB/TP53/CSNK2A2/GSK3B/PIK3CA/PIK3R1/MAPK1/MAPK3",17
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","5/81","10/2914",3.31486882635257e-06,4.05076970580284e-05,2.14245206250577e-05,"MAPK9/MAPK14/MAPK1/MAPK3/FOS",5
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","7/81","26/2914",4.24329206537755e-06,5.08363029793271e-05,2.68873202078618e-05,"PPARGC1A/FBXW7/GSK3B/STAT1/NR3C1/TWIST1/ESRRA",7
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","18/81","201/2914",5.53275075287324e-06,6.50098213462606e-05,3.43836939500422e-05,"AKT1/AKT2/AKT3/CSNK2A1/HDAC1/HDAC2/HDAC3/PML/PPP2CA/PPP2CB/PRKACA/TP53/CSNK2A2/GSK3B/PIK3CA/PIK3R1/MAPK1/MAPK3",18
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","5/81","11/2914",5.94517975688557e-06,6.7268607989946e-05,3.55783661864302e-05,"PPP2CA/PPP2CB/RB1/CDK1/E2F1",5
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","5/81","11/2914",5.94517975688557e-06,6.7268607989946e-05,3.55783661864302e-05,"AKT1/AKT2/AKT3/YWHAQ/YWHAZ",5
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","6/81","19/2914",7.78593959186146e-06,8.64947107386791e-05,4.57470517646214e-05,"HDAC3/RB1/AR/MAF/MAPK1/MAPK3",6
"R-HSA-400253","R-HSA-400253","Circadian Clock","9/81","52/2914",8.81121912153544e-06,9.42666783816075e-05,4.98576453840185e-05,"HDAC3/PPARGC1A/CREBBP/EP300/NR3C1/SREBF1/BHLHE40/MEF2C/CREM",9
"R-HSA-1643685","R-HSA-1643685","Disease","28/81","443/2914",9.33130762895357e-06,9.42666783816075e-05,4.98576453840185e-05,"AKT1/AKT2/AKT3/CTNNB1/HDAC1/HDAC2/HDAC3/PPP2CA/PPP2CB/PRKACA/CREBBP/FBXW7/RELA/EP300/GSK3B/JAK2/PIK3CA/PIK3R1/STAT1/STAT3/MAPK1/MAPK3/SMAD3/TCF7L2/NFKB1/SMAD4/TBP/CUX1",28
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","8/81","40/2914",9.40207342756965e-06,9.42666783816075e-05,4.98576453840185e-05,"HDAC3/PPARGC1A/CREBBP/RELA/EP300/NR2F2/NFKB1/SREBF1",8
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","7/81","29/2914",9.41123957655983e-06,9.42666783816075e-05,4.98576453840185e-05,"AKT1/AKT2/AKT3/TP53/E2F1/YWHAQ/YWHAZ",7
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","7/81","29/2914",9.41123957655983e-06,9.42666783816075e-05,4.98576453840185e-05,"AKT1/AKT2/AKT3/PPP2CA/PPP2CB/TP53/CDK1",7
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","7/81","29/2914",9.41123957655983e-06,9.42666783816075e-05,4.98576453840185e-05,"AKT1/AKT2/AKT3/PPP2CA/PPP2CB/TP53/CDK1",7
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","5/81","12/2914",9.97031528204599e-06,9.82558489891951e-05,5.19675176840088e-05,"PIK3CA/PIK3R1/STAT1/STAT3/CUX1",5
"R-HSA-373760","R-HSA-373760","L1CAM interactions","9/81","53/2914",1.03761610252467e-05,0.000100632291848027,5.32244182915744e-05,"CSNK2A1/PAK1/RPS6KA1/RPS6KA2/RPS6KA4/RPS6KA5/CSNK2A2/MAPK1/MAPK3",9
"R-HSA-109581","R-HSA-109581","Apoptosis","12/81","101/2914",1.50598830664537e-05,0.000142490985780183,7.53634811517205e-05,"AKT1/AKT2/AKT3/CTNNB1/HMGB1/TP53/E2F1/STAT3/YWHAQ/YWHAZ/MAPK1/MAPK3",12
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","7/81","31/2914",1.51586155085301e-05,0.000142490985780183,7.53634811517205e-05,"AKT1/AKT2/CTNNB1/HDAC1/YWHAZ/TCF7L2/SOX2",7
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","11/81","85/2914",1.55082181402573e-05,0.000143568504298443,7.59333806867464e-05,"AKT1/AKT2/AKT3/CTNNB1/PAK1/PRKACA/MAPK14/PIK3CA/PIK3R1/PRKCZ/MAPKAPK2",11
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","12/81","103/2914",1.84677070468339e-05,0.00016841446277038,8.90744079085309e-05,"AKT1/AKT2/AKT3/CTNNB1/HMGB1/TP53/E2F1/STAT3/YWHAQ/YWHAZ/MAPK1/MAPK3",12
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","12/81","104/2914",2.04115238218044e-05,0.000183403544928272,9.70021333327236e-05,"AKT1/HDAC1/HDAC2/HDAC3/TP53/CREBBP/FBXW7/E2F1/EP300/STAT1/YWHAZ/SMAD3",12
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","8/81","45/2914",2.35390220964083e-05,0.000205506765403283,0.00010869252645156,"RPS6KA1/RPS6KA2/RELA/STAT3/MAPK1/MAPK3/NFKB1/FOS",8
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","7/81","33/2914",2.3544146609214e-05,0.000205506765403283,0.00010869252645156,"PPP2CA/PPP2CB/SET/RB1/CDK1/MAPK1/MAPK3",7
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","6/81","23/2914",2.64969803177388e-05,0.000228023309494907,0.000120601526427662,"SP1/TP53/RB1/E2F1/MAPK1/MAPK3",6
"R-HSA-69206","R-HSA-69206","G1/S Transition","9/81","60/2914",2.95444233808737e-05,0.000250717259523804,0.00013260435640246,"AKT1/AKT2/AKT3/HDAC1/PPP2CA/PPP2CB/RB1/CDK1/E2F1",9
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","8/81","47/2914",3.28233652643101e-05,0.00027472707091087,0.000145303145438258,"HDAC3/PPARGC1A/SP1/CREBBP/EP300/ARNT/ESRRA/SREBF1",8
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","11/81","92/2914",3.33578276977667e-05,0.000275427469234263,0.000145673586105468,"AKT1/AKT2/AKT3/CTNNB1/PAK1/PRKACA/MAPK14/PIK3CA/PIK3R1/PRKCZ/MAPKAPK2",11
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","6/81","24/2914",3.45508495796307e-05,0.000277261150744924,0.000146643420240661,"AKT1/AKT2/AKT3/CREBBP/EP300/HNF4A",6
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","6/81","24/2914",3.45508495796307e-05,0.000277261150744924,0.000146643420240661,"AKT1/AKT2/AKT3/MAPK1/MAPK3/FOS",6
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","5/81","15/2914",3.53950405206286e-05,0.000277261150744924,0.000146643420240661,"AKT1/AKT2/AKT3/YWHAQ/YWHAZ",5
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","5/81","15/2914",3.53950405206286e-05,0.000277261150744924,0.000146643420240661,"HDAC1/HDAC2/EP300/GSK3B/TBP",5
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","23/81","347/2914",3.71222767802821e-05,0.00028711026725003,0.000151852617875371,"AKT1/AKT2/AKT3/CTNNB1/PAK1/PPP2CA/PPP2CB/PRKACA/RPS6KA1/RPS6KA2/RPS6KA5/JAK2/MAPK14/PIK3CA/PIK3R1/PRKCZ/STAT1/STAT3/MAPK1/MAPK3/MAPKAPK2/ATF1/MEF2C",23
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","10/81","77/2914",3.7947184045657e-05,0.000289821618148705,0.000153286651342325,"AKT1/AKT2/AKT3/HDAC1/PPP2CA/PPP2CB/RB1/CDK1/E2F1/JAK2",10
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","8/81","48/2914",3.85086628017029e-05,0.000290478925578277,0.000153634301236163,"HDAC3/PPARGC1A/SP1/CREBBP/EP300/ARNT/ESRRA/SREBF1",8
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","9/81","63/2914",4.41966683595267e-05,0.000329319077654522,0.00017417685733472,"AKT1/AKT2/AKT3/PIK3CA/PIK3R1/PRKCZ/MAPK1/MAPK3/FOS",9
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","8/81","49/2914",4.49950867209327e-05,0.000331228891403492,0.000175186957810099,"HDAC1/SP1/CREBBP/EP300/YY1/MYB/TBP/FOS",8
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","7/81","38/2914",6.2160685643647e-05,0.00045214498724129,0.000239139479857138,"HDAC3/PPARGC1A/CREBBP/MAPK14/ESRRA/GABPA/MEF2C",7
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","6/81","27/2914",7.10749642571276e-05,0.000510903566601235,0.000270216891974467,"PML/E2F1/EP300/STAT3/FLI1/MYB",6
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","8/81","53/2914",8.07947355704172e-05,0.000574018412017731,0.00030359833317158,"AKT1/AKT2/AKT3/PAK1/PPP2CA/PPP2CB/PIK3CA/PIK3R1",8
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","4/81","10/2914",0.000102515166777883,0.000711781442060072,0.000376461198574282,"PPP2CA/PPP2CB/RB1/E2F1",4
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","4/81","10/2914",0.000102515166777883,0.000711781442060072,0.000376461198574282,"AKT1/AKT2/AKT3/TP53",4
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","5/81","19/2914",0.000125549300252304,0.000861917106226491,0.000455867950058632,"AKT1/AKT2/AKT3/PPP2CA/PPP2CB",5
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","6/81","30/2914",0.000133363115287216,0.000905387371560989,0.000478859373019595,"CSNK2A1/HDAC3/TP53/CSNK2A2/FBXW7/STAT3",6
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","11/81","107/2914",0.00013697766643956,0.000919707188951333,0.000486433124313996,"HDAC1/HDAC2/PML/PPARGC1A/TP53/CREBBP/RELA/AR/EP300/UBE2I/NR3C1",11
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","4/81","11/2914",0.000157698016504167,0.00103160257142739,0.000545614591141717,"AKT1/AKT2/AKT3/HNF4A",4
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","6/81","31/2914",0.000161732195234101,0.00103160257142739,0.000545614591141717,"AKT1/AKT2/AKT3/PAK1/PIK3CA/PIK3R1",6
"R-HSA-391251","R-HSA-391251","Protein folding","6/81","31/2914",0.000161732195234101,0.00103160257142739,0.000545614591141717,"CSNK2A1/HDAC3/TP53/CSNK2A2/FBXW7/STAT3",6
"R-HSA-2990846","R-HSA-2990846","SUMOylation","11/81","109/2914",0.00016212377638054,0.00103160257142739,0.000545614591141717,"HDAC1/HDAC2/PML/PPARGC1A/TP53/CREBBP/RELA/AR/EP300/UBE2I/NR3C1",11
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","5/81","20/2914",0.000163773239653776,0.00103160257142739,0.000545614591141717,"RPS6KA1/RPS6KA2/RPS6KA4/RPS6KA5/MAPK1",5
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","5/81","20/2914",0.000163773239653776,0.00103160257142739,0.000545614591141717,"CSNK2A1/PAK1/CSNK2A2/MAPK1/MAPK3",5
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","6/81","32/2914",0.000194676933236934,0.00120149097179563,0.000635468564633055,"HDAC3/PPARGC1A/CREBBP/ESRRA/GABPA/MEF2C",6
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","6/81","32/2914",0.000194676933236934,0.00120149097179563,0.000635468564633055,"HDAC1/HDAC2/HDAC3/TP53/MAPK1/MAPK3",6
"R-HSA-195721","R-HSA-195721","Signaling by WNT","14/81","172/2914",0.000205235251279365,0.00125398738531692,0.000663233917292265,"AKT1/AKT2/CSNK2A1/CTNNB1/HDAC1/PPP2CA/PPP2CB/CREBBP/CSNK2A2/EP300/GSK3B/YWHAZ/TCF7L2/SOX2",14
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","5/81","21/2914",0.000210298404319182,0.0012722012380101,0.000672867223824792,"AKT1/AKT2/AKT3/PIK3CA/PIK3R1",5
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","10/81","94/2914",0.000212850491187521,0.00127501617760368,0.000674356045351588,"AKT1/TP53/JAK2/PIK3R1/STAT1/STAT3/TWIST1/SOX2/BCL6/FOS",10
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","4/81","12/2914",0.000231561867115227,0.00137363398842139,0.000726515004643584,"PPP2CA/PPP2CB/MAPK1/MAPK3",4
"R-HSA-1430728","R-HSA-1430728","Metabolism","19/81","289/2914",0.000236962072273807,0.00139215217460862,0.000736309273158491,"AKT1/CSNK2A1/HDAC3/PPARGC1A/PPP2CA/PPP2CB/PRKACA/SP1/CREBBP/CSNK2A2/EP300/PIK3CA/PIK3R1/STK11/UBE2I/MAPKAPK2/ARNT/ESRRA/SREBF1",19
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","5/81","22/2914",0.000266260852543323,0.00154938458003781,0.000819469491035592,"CTNNB1/HDAC1/CREBBP/EP300/TCF7L2",5
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","9/81","80/2914",0.000294771620837606,0.00169910811633752,0.000898658268094786,"HDAC3/PPARGC1A/PRKACA/CREBBP/CDK1/MAPK14/ESRRA/GABPA/MEF2C",9
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","6/81","35/2914",0.000326207516315917,0.00183543196677943,0.000970759951419216,"AKT1/AKT2/AKT3/TP53/YWHAQ/YWHAZ",6
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","4/81","13/2914",0.000327433853320716,0.00183543196677943,0.000970759951419216,"AKT1/AKT2/AKT3/GSK3B",4
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","4/81","13/2914",0.000327433853320716,0.00183543196677943,0.000970759951419216,"CREBBP/EP300/STK11/BCL6",4
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","5/81","24/2914",0.000411364843577833,0.00226435963446897,0.00119761979116543,"PIK3CA/PIK3R1/STAT1/STAT3/CUX1",5
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","5/81","24/2914",0.000411364843577833,0.00226435963446897,0.00119761979116543,"JAK2/STAT1/STAT3/MAPK1/MAPK3",5
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","6/81","37/2914",0.000446909521313369,0.00228493297090441,0.00120850102862891,"CTNNB1/HDAC1/PPP2CA/PPP2CB/GSK3B/TCF7L2",6
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","6/81","37/2914",0.000446909521313369,0.00228493297090441,0.00120850102862891,"PPP2CA/PPP2CB/PIK3CA/PIK3R1/MAPK1/MAPK3",6
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","4/81","14/2914",0.00044875933962116,0.00228493297090441,0.00120850102862891,"PPP2CA/PPP2CB/MAPK1/MAPK3",4
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","4/81","14/2914",0.00044875933962116,0.00228493297090441,0.00120850102862891,"CTNNB1/PPP2CA/PPP2CB/GSK3B",4
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","4/81","14/2914",0.00044875933962116,0.00228493297090441,0.00120850102862891,"CTNNB1/PPP2CA/PPP2CB/GSK3B",4
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","4/81","14/2914",0.00044875933962116,0.00228493297090441,0.00120850102862891,"CTNNB1/PPP2CA/PPP2CB/GSK3B",4
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","4/81","14/2914",0.00044875933962116,0.00228493297090441,0.00120850102862891,"CTNNB1/PPP2CA/PPP2CB/GSK3B",4
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","4/81","14/2914",0.00044875933962116,0.00228493297090441,0.00120850102862891,"CTNNB1/PPP2CA/PPP2CB/GSK3B",4
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","4/81","14/2914",0.00044875933962116,0.00228493297090441,0.00120850102862891,"CTNNB1/PPP2CA/PPP2CB/GSK3B",4
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","5/81","25/2914",0.000503091018241409,0.00251957878807788,0.00133260519931072,"AKT1/AKT2/AKT3/CTNNB1/PAK1",5
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","5/81","25/2914",0.000503091018241409,0.00251957878807788,0.00133260519931072,"AKT1/AKT2/AKT3/CSNK2A1/CSNK2A2",5
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","6/81","38/2914",0.000519049928001443,0.00257836996755188,0.0013636998536281,"PPP2CA/PPP2CB/PIK3CA/PIK3R1/MAPK1/MAPK3",6
"R-HSA-68886","R-HSA-68886","M Phase","10/81","105/2914",0.000529359992482195,0.00260837867263404,0.00137957145748755,"CSNK2A1/PPP2CA/PPP2CB/PRKACA/SET/CSNK2A2/RB1/CDK1/MAPK1/MAPK3",10
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","7/81","53/2914",0.000542197757502111,0.00265026263867032,0.00140172388676335,"CTNNB1/TP53/CREBBP/EP300/SMAD3/TCF7L2/SMAD4",7
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","9/81","87/2914",0.000556474393815814,0.0026984591636624,0.0014272150284165,"MAPK9/PAK1/RELA/PIK3CA/PIK3R1/MAPK1/MAPK3/NFKB1/FOS",9
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","6/81","40/2914",0.000690335639029188,0.00329527402692839,0.00174287040445691,"HDAC1/HDAC2/HDAC3/CREBBP/FBXW7/EP300",6
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","6/81","40/2914",0.000690335639029188,0.00329527402692839,0.00174287040445691,"AKT1/CREBBP/FBXW7/EP300/YWHAZ/SMAD3",6
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","11/81","130/2914",0.000763127930607194,0.00361450515969764,0.00191171174782871,"CTNNB1/PAK1/PPP2CA/PPP2CB/AR/MAPK14/PRKCZ/YWHAQ/YWHAZ/MAPK1/MAPK3",11
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","4/81","16/2914",0.000781975893062105,0.0036335341341083,0.0019217761722306,"CTNNB1/PPP2CA/PPP2CB/GSK3B",4
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","4/81","16/2914",0.000781975893062105,0.0036335341341083,0.0019217761722306,"MAPK14/PRKCZ/MAPK1/MAPK3",4
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","6/81","41/2914",0.000790932962089042,0.0036335341341083,0.0019217761722306,"PPP2CA/PPP2CB/PIK3CA/PIK3R1/MAPK1/MAPK3",6
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","6/81","41/2914",0.000790932962089042,0.0036335341341083,0.0019217761722306,"HDAC1/HDAC2/HDAC3/PRKACA/SOX2/MEF2C",6
"R-HSA-168249","R-HSA-168249","Innate Immune System","23/81","428/2914",0.000927251104644496,0.00422798824580438,0.00223618294678602,"CTNNB1/HMGB1/MAPK9/PAK1/PPP2CA/PPP2CB/PRKACA/RPS6KA1/RPS6KA2/RPS6KA5/CREBBP/RELA/EP300/MAPK14/PIK3CA/PIK3R1/MAPK1/MAPK3/MAPKAPK2/ATF1/NFKB1/FOS/MEF2C",23
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","5/81","30/2914",0.00120989504379794,0.00547589534637439,0.00289620100152802,"MAPK9/PAK1/MAPK1/MAPK3/FOS",5
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","4/81","18/2914",0.00126011838330694,0.00566126714853339,0.00299424414609312,"RPS6KA1/RPS6KA2/MAPK1/MAPK3",4
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","5/81","31/2914",0.00141146482236791,0.006171053251037,0.00326387001131598,"AKT1/SET/MAPK14/YWHAZ/MAPKAPK2",5
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","5/81","31/2914",0.00141146482236791,0.006171053251037,0.00326387001131598,"CTNNB1/PPP2CA/PPP2CB/GSK3B/TCF7L2",5
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","5/81","31/2914",0.00141146482236791,0.006171053251037,0.00326387001131598,"PIK3CA/PIK3R1/STAT1/STAT3/CUX1",5
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","7/81","62/2914",0.00141398928828998,0.006171053251037,0.00326387001131598,"HDAC1/HDAC2/PRKACA/TP53/JAK2/IRF1/MYB",7
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","9/81","99/2914",0.00143153833333384,0.00620333277777996,0.00328094265273228,"AKT1/AKT2/AKT3/PPP2CA/PPP2CB/PIK3CA/PIK3R1/MAPK1/MAPK3",9
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","4/81","20/2914",0.00191239436357178,0.00817113955344304,0.00432171563942978,"HDAC1/HDAC2/MAPK3/TBP",4
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","4/81","20/2914",0.00191239436357178,0.00817113955344304,0.00432171563942978,"HDAC1/HDAC2/MAPK3/TBP",4
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","6/81","49/2914",0.00206018746715279,0.00874148987798859,0.00462337392116892,"CREBBP/EP300/GSK3B/MAPK1/MAPK3/MAPKAPK2",6
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","3/81","10/2914",0.00215701511043338,0.00887923826733662,0.00469622904310853,"CDK1/JAK2/MAPK3",3
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","3/81","10/2914",0.00215701511043338,0.00887923826733662,0.00469622904310853,"HDAC1/CDK1/E2F1",3
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","3/81","10/2914",0.00215701511043338,0.00887923826733662,0.00469622904310853,"EP300/GSK3B/TBP",3
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","3/81","10/2914",0.00215701511043338,0.00887923826733662,0.00469622904310853,"JAK2/STAT1/STAT3",3
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","5/81","34/2914",0.00216531342362219,0.00887923826733662,0.00469622904310853,"CTNNB1/CREBBP/RELA/EP300/NFKB1",5
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","6/81","50/2914",0.002289877484611,0.00932743428731545,0.00493327991421456,"PPP2CA/PPP2CB/PIK3CA/PIK3R1/MAPK1/MAPK3",6
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","4/81","21/2914",0.00231288753045474,0.00935877007356188,0.00494985341129037,"AKT1/AKT2/AKT3/PAK1",4
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","7/81","68/2914",0.00243712247612025,0.00979659100598337,0.00518141689867671,"PPP2CA/PPP2CB/PRKACA/TP53/CDK1/E2F1/EP300",7
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","6/81","51/2914",0.00253840536274993,0.00987876227159367,0.00522487728035017,"HDAC1/HDAC2/HDAC3/CREBBP/FBXW7/EP300",6
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","6/81","51/2914",0.00253840536274993,0.00987876227159367,0.00522487728035017,"HDAC1/HDAC2/HDAC3/CREBBP/FBXW7/EP300",6
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","6/81","51/2914",0.00253840536274993,0.00987876227159367,0.00522487728035017,"HDAC1/HDAC2/HDAC3/CREBBP/FBXW7/EP300",6
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","6/81","51/2914",0.00253840536274993,0.00987876227159367,0.00522487728035017,"HDAC1/HDAC2/HDAC3/CREBBP/FBXW7/EP300",6
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","6/81","51/2914",0.00253840536274993,0.00987876227159367,0.00522487728035017,"HDAC1/HDAC2/HDAC3/CREBBP/FBXW7/EP300",6
"R-HSA-109582","R-HSA-109582","Hemostasis","17/81","298/2914",0.00268248323702854,0.0103734003659775,0.00548649136420894,"AKT1/HDAC1/HDAC2/PPP2CA/PPP2CB/PRKACA/TP53/JAK2/MAPK14/PIK3CA/PIK3R1/PRKCZ/YWHAZ/MAPK1/MAPK3/IRF1/MYB",17
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","4/81","22/2914",0.0027676934588795,0.0105691293960961,0.00559001244655268,"RPS6KA1/RPS6KA2/MAPK1/MAPK3",4
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","4/81","22/2914",0.0027676934588795,0.0105691293960961,0.00559001244655268,"HDAC1/HDAC2/HDAC3/PRKACA",4
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","3/81","11/2914",0.00290675902065684,0.0106989744675984,0.00565868750375174,"JAK2/STAT1/STAT3",3
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","3/81","11/2914",0.00290675902065684,0.0106989744675984,0.00565868750375174,"AKT1/AKT2/AKT3",3
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","3/81","11/2914",0.00290675902065684,0.0106989744675984,0.00565868750375174,"STAT3/SOX2/SMAD4",3
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","3/81","11/2914",0.00290675902065684,0.0106989744675984,0.00565868750375174,"CDK1/YWHAQ/YWHAZ",3
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","3/81","11/2914",0.00290675902065684,0.0106989744675984,0.00565868750375174,"JAK2/STAT1/STAT3",3
"R-HSA-9027276","R-HSA-9027276","Erythropoietin activates Phosphoinositide-3-kinase (PI3K)","3/81","11/2914",0.00290675902065684,0.0106989744675984,0.00565868750375174,"JAK2/PIK3CA/PIK3R1",3
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","5/81","37/2914",0.00317780360080792,0.0116265748508601,0.00614929533846853,"HDAC1/HDAC2/EP300/GSK3B/TBP",5
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","4/81","23/2914",0.0032802895706096,0.0118595084475885,0.0062724939157717,"CDK1/JAK2/MAPK1/MAPK3",4
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","4/81","23/2914",0.0032802895706096,0.0118595084475885,0.0062724939157717,"TP53/CREBBP/E2F1/EP300",4
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","7/81","72/2914",0.00338653484106489,0.0121716046346509,0.00643756158642057,"PAK1/PRKACA/RPS6KA5/CREBBP/RELA/EP300/NFKB1",7
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","6/81","55/2914",0.00374022240198493,0.0133641864772678,0.00706831811270774,"PPP2CA/PPP2CB/PIK3CA/PIK3R1/MAPK1/MAPK3",6
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","3/81","12/2914",0.00379849140517072,0.0133797700527599,0.0070765602656513,"HDAC1/HDAC3/PRKACA",3
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","3/81","12/2914",0.00379849140517072,0.0133797700527599,0.0070765602656513,"HDAC1/HDAC3/PRKACA",3
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","4/81","24/2914",0.00385407451601595,0.0133797700527599,0.0070765602656513,"HDAC1/SP1/SMAD3/SMAD4",4
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","4/81","24/2914",0.00385407451601595,0.0133797700527599,0.0070765602656513,"PAK1/AR/YWHAQ/YWHAZ",4
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","4/81","24/2914",0.00385407451601595,0.0133797700527599,0.0070765602656513,"AKT1/AKT2/AKT3/GSK3B",4
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","5/81","39/2914",0.00401898193067089,0.0138734348002255,0.00733765954633342,"AKT1/AKT2/AKT3/RB1/E2F1",5
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","6/81","56/2914",0.0040975233727741,0.013986518328296,0.00739746942335578,"CSNK2A1/TP53/CSNK2A2/MAPK14/STK11/TBP",6
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","6/81","56/2914",0.0040975233727741,0.013986518328296,0.00739746942335578,"CSNK2A1/PPP2CA/PPP2CB/PRKACA/CSNK2A2/CDK1",6
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","4/81","25/2914",0.00449235708702062,0.0150062362230074,0.0079367982090848,"CREBBP/EP300/UBE2I/YY1",4
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","5/81","40/2914",0.00449450282947685,0.0150062362230074,0.0079367982090848,"PPP2CA/PPP2CB/RB1/E2F1/JAK2",5
"R-HSA-69236","R-HSA-69236","G1 Phase","5/81","40/2914",0.00449450282947685,0.0150062362230074,0.0079367982090848,"PPP2CA/PPP2CB/RB1/E2F1/JAK2",5
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","5/81","40/2914",0.00449450282947685,0.0150062362230074,0.0079367982090848,"AKT1/AKT2/AKT3/RB1/E2F1",5
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","3/81","13/2914",0.00483980867072572,0.0154823198838399,0.00818859885319811,"CREBBP/EP300/SREBF1",3
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","3/81","13/2914",0.00483980867072572,0.0154823198838399,0.00818859885319811,"PPP2CA/PPP2CB/GSK3B",3
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","3/81","13/2914",0.00483980867072572,0.0154823198838399,0.00818859885319811,"PPP2CA/PPP2CB/GSK3B",3
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","3/81","13/2914",0.00483980867072572,0.0154823198838399,0.00818859885319811,"PPP2CA/PPP2CB/GSK3B",3
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","3/81","13/2914",0.00483980867072572,0.0154823198838399,0.00818859885319811,"PPP2CA/PPP2CB/GSK3B",3
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","3/81","13/2914",0.00483980867072572,0.0154823198838399,0.00818859885319811,"PPP2CA/PPP2CB/GSK3B",3
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","3/81","13/2914",0.00483980867072572,0.0154823198838399,0.00818859885319811,"PPP2CA/PPP2CB/GSK3B",3
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","3/81","13/2914",0.00483980867072572,0.0154823198838399,0.00818859885319811,"AKT1/AKT2/AKT3",3
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","5/81","41/2914",0.00500888753328072,0.0158571517245312,0.00838684741051094,"JAK2/PIK3CA/PIK3R1/STAT1/STAT3",5
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","5/81","41/2914",0.00500888753328072,0.0158571517245312,0.00838684741051094,"JAK2/PIK3CA/PIK3R1/STAT1/STAT3",5
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","4/81","26/2914",0.00519834633686532,0.0162881518555113,0.0086148033760737,"AKT1/AKT2/YWHAQ/YWHAZ",4
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","4/81","26/2914",0.00519834633686532,0.0162881518555113,0.0086148033760737,"HDAC1/HDAC2/HDAC3/CREBBP",4
"R-HSA-165159","R-HSA-165159","mTOR signalling","4/81","27/2914",0.00597514283081552,0.0183457902996396,0.00970308833144863,"AKT1/AKT2/STK11/RPS6KB1",4
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","4/81","27/2914",0.00597514283081552,0.0183457902996396,0.00970308833144863,"HDAC3/CREBBP/EP300/YY1",4
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","4/81","27/2914",0.00597514283081552,0.0183457902996396,0.00970308833144863,"HDAC3/CREBBP/EP300/YY1",4
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","4/81","27/2914",0.00597514283081552,0.0183457902996396,0.00970308833144863,"PPP2CA/PPP2CB/MAPK1/MAPK3",4
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","3/81","14/2914",0.00603736757920875,0.0184441579544827,0.00975511498324783,"SP1/CREBBP/SREBF1",3
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","5/81","44/2914",0.006801812279419,0.0205444414479012,0.010865954904825,"AKT1/AKT2/AKT3/PIK3CA/PIK3R1",5
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","4/81","28/2914",0.00682573095568567,0.0205444414479012,0.010865954904825,"PPP2CA/PPP2CB/MAPK1/MAPK3",4
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","4/81","28/2914",0.00682573095568567,0.0205444414479012,0.010865954904825,"SP1/CREBBP/UBE2I/SREBF1",4
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","3/81","15/2914",0.00739694106646015,0.0217285143827267,0.0114922110698546,"HDAC1/HDAC2/TBP",3
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","3/81","15/2914",0.00739694106646015,0.0217285143827267,0.0114922110698546,"PPP2CA/PPP2CB/MAPK14",3
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","3/81","15/2914",0.00739694106646015,0.0217285143827267,0.0114922110698546,"TP53/CDK1/EP300",3
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","3/81","15/2914",0.00739694106646015,0.0217285143827267,0.0114922110698546,"HDAC1/CDK1/E2F1",3
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","3/81","15/2914",0.00739694106646015,0.0217285143827267,0.0114922110698546,"AKT1/FBXW7/YWHAZ",3
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","5/81","45/2914",0.00748814562925931,0.0217869379975116,0.0115231113192111,"PIK3CA/PIK3R1/STAT1/STAT3/CUX1",5
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","5/81","45/2914",0.00748814562925931,0.0217869379975116,0.0115231113192111,"PRKACA/JAK2/PIK3CA/PIK3R1/YWHAZ",5
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","4/81","29/2914",0.00775297221968132,0.0223446510671004,0.0118180857569124,"PIK3CA/PIK3R1/STAT1/STAT3",4
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","4/81","29/2914",0.00775297221968132,0.0223446510671004,0.0118180857569124,"TP53/CREBBP/E2F1/EP300",4
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","6/81","64/2914",0.00793111891888905,0.0227507683541841,0.0120328811865527,"HDAC1/HDAC2/HDAC3/CREBBP/FBXW7/EP300",6
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","4/81","30/2914",0.00875959947750953,0.0246641257177803,0.0130448558796771,"CSNK2A1/CSNK2A2/PIK3CA/PIK3R1",4
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","4/81","30/2914",0.00875959947750953,0.0246641257177803,0.0130448558796771,"CTNNB1/PPP2CA/PPP2CB/GSK3B",4
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","4/81","30/2914",0.00875959947750953,0.0246641257177803,0.0130448558796771,"PPP2CA/PPP2CB/MAPK1/MAPK3",4
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","4/81","30/2914",0.00875959947750953,0.0246641257177803,0.0130448558796771,"TP53/CDK1/E2F1/EP300",4
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","3/81","16/2914",0.00892347149109048,0.0248759120010566,0.0131568696430776,"HDAC1/HDAC2/HDAC3",3
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","3/81","16/2914",0.00892347149109048,0.0248759120010566,0.0131568696430776,"AKT1/AKT2/AKT3",3
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","5/81","47/2914",0.00900337949142699,0.0248759120010566,0.0131568696430776,"PRKACA/RPS6KA1/RPS6KA2/MAPK1/MAPK3",5
"R-HSA-422475","R-HSA-422475","Axon guidance","14/81","254/2914",0.00900547261266712,0.0248759120010566,0.0131568696430776,"CSNK2A1/PAK1/PRKACA/RPS6KA1/RPS6KA2/RPS6KA4/RPS6KA5/CSNK2A2/GSK3B/MAPK14/PIK3CA/PIK3R1/MAPK1/MAPK3",14
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","7/81","86/2914",0.0090383837385181,0.0248759120010566,0.0131568696430776,"CSNK2A1/HDAC1/PML/CREBBP/CSNK2A2/EP300/MYB",7
"R-HSA-69275","R-HSA-69275","G2/M Transition","6/81","66/2914",0.00919732794090737,0.0251998536856251,0.0133282023972554,"PPP2CA/PPP2CB/PRKACA/TP53/CDK1/EP300",6
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","8/81","109/2914",0.00981006575665611,0.0266397785658528,0.0140897786540043,"HDAC1/HDAC2/HDAC3/CREBBP/RELA/EP300/JAK2/NFKB1",8
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","8/81","109/2914",0.00981006575665611,0.0266397785658528,0.0140897786540043,"HDAC1/HDAC2/HDAC3/CREBBP/RELA/EP300/JAK2/NFKB1",8
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","3/81","17/2914",0.0106211214161452,0.0285881285694481,0.0151202609541228,"HDAC1/HDAC2/TBP",3
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","3/81","17/2914",0.0106211214161452,0.0285881285694481,0.0151202609541228,"CREBBP/EP300/SMAD3",3
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","5/81","49/2914",0.0107188966779125,0.0287247625886164,0.0151925266856839,"PRKACA/RPS6KA1/RPS6KA2/MAPK1/MAPK3",5
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","4/81","32/2914",0.0110212714627355,0.0292782472336147,0.0154852647096558,"GSK3B/MAPK1/MAPK3/MAPKAPK2",4
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","4/81","32/2914",0.0110212714627355,0.0292782472336147,0.0154852647096558,"PPP2CA/PPP2CB/MAPK1/MAPK3",4
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","4/81","33/2914",0.0122810983988744,0.0324837710896634,0.0171806662495075,"MAPK14/MAPK1/MAPK3/MAPKAPK2",4
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","3/81","18/2914",0.0124933220227128,0.0326214519481947,0.0172534856543988,"PPP2CA/PPP2CB/CDK1",3
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","3/81","18/2914",0.0124933220227128,0.0326214519481947,0.0172534856543988,"CSNK2A1/CSNK2A2/EP300",3
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","3/81","18/2914",0.0124933220227128,0.0326214519481947,0.0172534856543988,"CREBBP/EP300/STAT1",3
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","7/81","92/2914",0.0128938711157761,0.0335240649010178,0.0177308776373718,"AKT1/PPP2CA/PPP2CB/PIK3CA/PIK3R1/MAPK1/MAPK3",7
"R-HSA-69242","R-HSA-69242","S Phase","6/81","71/2914",0.012987894119807,0.0336254377423818,0.017784493732296,"AKT1/AKT2/AKT3/RB1/E2F1/GSK3B",6
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","4/81","34/2914",0.013629869728908,0.0350065049107635,0.0185149401457566,"PPP2CA/PPP2CB/MAPK1/MAPK3",4
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","5/81","52/2914",0.0136932155051923,0.0350065049107635,0.0185149401457566,"AKT2/PIK3CA/PIK3R1/MAPK1/MAPK3",5
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","5/81","52/2914",0.0136932155051923,0.0350065049107635,0.0185149401457566,"AKT2/PIK3CA/PIK3R1/MAPK1/MAPK3",5
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","3/81","19/2914",0.0145428192509487,0.0368699691382974,0.0195005263596474,"HDAC1/CDK1/E2F1",3
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","3/81","19/2914",0.0145428192509487,0.0368699691382974,0.0195005263596474,"HDAC1/HDAC2/TBP",3
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","4/81","36/2914",0.0166022232509733,0.0416565835433205,0.0220321666772322,"HDAC1/SP1/SMAD3/SMAD4",4
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","3/81","20/2914",0.0167717177604858,0.0416565835433205,0.0220321666772322,"SP1/CREBBP/SREBF1",3
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","3/81","20/2914",0.0167717177604858,0.0416565835433205,0.0220321666772322,"HDAC1/SMAD3/SMAD4",3
"R-HSA-70171","R-HSA-70171","Glycolysis","3/81","20/2914",0.0167717177604858,0.0416565835433205,0.0220321666772322,"PPP2CA/PPP2CB/PRKACA",3
"R-HSA-70326","R-HSA-70326","Glucose metabolism","3/81","20/2914",0.0167717177604858,0.0416565835433205,0.0220321666772322,"PPP2CA/PPP2CB/PRKACA",3
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","4/81","37/2914",0.0182294256328115,0.0450938423548496,0.0238501328330413,"PPARGC1A/CREBBP/EP300/UBE2I",4
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","3/81","21/2914",0.0191815227988244,0.0472577033471036,0.0249945988932049,"HMGB1/RELA/NFKB1",3
"R-HSA-180024","R-HSA-180024","DARPP-32 events","3/81","22/2914",0.0217731800630262,0.0530016454920677,0.0280325698441981,"PPP2CA/PPP2CB/PRKACA",3
"R-HSA-525793","R-HSA-525793","Myogenesis","3/81","22/2914",0.0217731800630262,0.0530016454920677,0.0280325698441981,"CTNNB1/MAPK14/MEF2C",3
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","3/81","22/2914",0.0217731800630262,0.0530016454920677,0.0280325698441981,"HDAC3/EP300/SREBF1",3
"R-HSA-202403","R-HSA-202403","TCR signaling","5/81","59/2914",0.0226881003248505,0.0550096400733478,0.0290945981609403,"PAK1/RELA/PIK3CA/PIK3R1/NFKB1",5
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","3/81","23/2914",0.0245471136368886,0.0590483717800746,0.0312306833258384,"HDAC1/HDAC2/UBE2I",3
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","3/81","23/2914",0.0245471136368886,0.0590483717800746,0.0312306833258384,"JAK2/STAT1/STAT3",3
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","5/81","62/2914",0.0274968890182215,0.0648822128669752,0.0343162018264474,"PAK1/PIK3CA/PIK3R1/MAPK1/MAPK3",5
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","3/81","24/2914",0.0275032620827276,0.0648822128669752,0.0343162018264474,"CREBBP/EP300/ARNT",3
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","3/81","24/2914",0.0275032620827276,0.0648822128669752,0.0343162018264474,"JAK2/STAT1/STAT3",3
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","3/81","24/2914",0.0275032620827276,0.0648822128669752,0.0343162018264474,"AKT1/AKT2/AKT3",3
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","3/81","24/2914",0.0275032620827276,0.0648822128669752,0.0343162018264474,"JAK2/PIK3CA/PIK3R1",3
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","5/81","63/2914",0.029233888786335,0.067248971917817,0.0355679806680503,"HDAC1/SP1/PRKCZ/SMAD3/SMAD4",5
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/81","10/2914",0.0297172216330779,0.067248971917817,0.0355679806680503,"MAPK1/MAPK3",2
"R-HSA-1250342","R-HSA-1250342","PI3K events in ERBB4 signaling","2/81","10/2914",0.0297172216330779,0.067248971917817,0.0355679806680503,"PIK3CA/PIK3R1",2
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","2/81","10/2914",0.0297172216330779,0.067248971917817,0.0355679806680503,"RELA/NFKB1",2
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","2/81","10/2914",0.0297172216330779,0.067248971917817,0.0355679806680503,"RELA/UBE2I",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/81","10/2914",0.0297172216330779,0.067248971917817,0.0355679806680503,"MAPK1/MAPK3",2
"R-HSA-8853334","R-HSA-8853334","Signaling by FGFR3 fusions in cancer","2/81","10/2914",0.0297172216330779,0.067248971917817,0.0355679806680503,"PIK3CA/PIK3R1",2
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","2/81","10/2914",0.0297172216330779,0.067248971917817,0.0355679806680503,"CSNK2A1/CSNK2A2",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/81","10/2914",0.0297172216330779,0.067248971917817,0.0355679806680503,"STAT1/STAT3",2
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","2/81","10/2914",0.0297172216330779,0.067248971917817,0.0355679806680503,"CREBBP/EP300",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/81","10/2914",0.0297172216330779,0.067248971917817,0.0355679806680503,"MAPK1/MAPK3",2
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","4/81","43/2914",0.0300577357037597,0.0677685480258198,0.0358427844670974,"RELA/PIK3CA/PIK3R1/NFKB1",4
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","3/81","25/2914",0.0306411127639604,0.0688298525690434,0.0364041084308663,"AKT1/AKT2/AKT3",3
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","3/81","26/2914",0.0339597344718424,0.0760051200084091,0.040199107317739,"JAK2/PIK3CA/PIK3R1",3
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","5/81","66/2914",0.0348574821453727,0.0777296408424188,0.0411112063719917,"HMGB1/CREBBP/RELA/EP300/NFKB1",5
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","2/81","11/2914",0.0356751022136159,0.0778481694732833,0.0411738961638349,"HDAC1/E2F1",2
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","2/81","11/2914",0.0356751022136159,0.0778481694732833,0.0411738961638349,"RELA/NFKB1",2
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","2/81","11/2914",0.0356751022136159,0.0778481694732833,0.0411738961638349,"JAK2/STAT3",2
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","2/81","11/2914",0.0356751022136159,0.0778481694732833,0.0411738961638349,"CREBBP/EP300",2
"R-HSA-5655291","R-HSA-5655291","Signaling by FGFR4 in disease","2/81","11/2914",0.0356751022136159,0.0778481694732833,0.0411738961638349,"PIK3CA/PIK3R1",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/81","11/2914",0.0356751022136159,0.0778481694732833,0.0411738961638349,"TP53/E2F1",2
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","4/81","46/2914",0.0373445684997257,0.080871805473071,0.042773097218077,"AR/NR3C1/ESRRA/HNF4A",4
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","4/81","46/2914",0.0373445684997257,0.080871805473071,0.042773097218077,"TP53/CDK1/YWHAQ/YWHAZ",4
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","3/81","27/2914",0.0374578084269707,0.080871805473071,0.042773097218077,"HMGB1/RELA/NFKB1",3
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","4/81","47/2914",0.0399809581749163,0.0860153712847671,0.0454935291315764,"PML/JAK2/STAT1/IRF1",4
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","3/81","28/2914",0.0411336577235249,0.0873905078003786,0.0462208388228379,"PIK3CA/PIK3R1/PRKCZ",3
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","3/81","28/2914",0.0411336577235249,0.0873905078003786,0.0462208388228379,"AR/UBE2I/NR3C1",3
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/81","12/2914",0.0420504243753049,0.0873905078003786,0.0462208388228379,"MAPK1/MAPK3",2
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","2/81","12/2914",0.0420504243753049,0.0873905078003786,0.0462208388228379,"CSNK2A1/CSNK2A2",2
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/81","12/2914",0.0420504243753049,0.0873905078003786,0.0462208388228379,"SMAD3/SMAD4",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/81","12/2914",0.0420504243753049,0.0873905078003786,0.0462208388228379,"MAPK1/MAPK3",2
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","2/81","12/2914",0.0420504243753049,0.0873905078003786,0.0462208388228379,"CREBBP/EP300",2
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","2/81","12/2914",0.0420504243753049,0.0873905078003786,0.0462208388228379,"CTNNB1/TCF7L2",2
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","2/81","12/2914",0.0420504243753049,0.0873905078003786,0.0462208388228379,"RELA/NFKB1",2
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","2/81","12/2914",0.0420504243753049,0.0873905078003786,0.0462208388228379,"HDAC1/HDAC2",2
"R-HSA-5673000","R-HSA-5673000","RAF activation","3/81","29/2914",0.0449852752816608,0.0931728921935414,0.0492791418785722,"PPP2CA/PPP2CB/JAK2",3
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","4/81","49/2914",0.0455661405290075,0.0940571346730527,0.0497468177183688,"PIK3CA/PIK3R1/STAT1/STAT3",4
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","11/81","228/2914",0.0482153002295763,0.0984375261378398,0.052063606726362,"CTNNB1/PAK1/PPP2CA/PPP2CB/AR/MAPK14/PRKCZ/YWHAQ/YWHAZ/MAPK1/MAPK3",11
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/81","13/2914",0.0488159908670466,0.0984375261378398,0.052063606726362,"MAPK1/MAPK3",2
"R-HSA-171007","R-HSA-171007","p38MAPK events","2/81","13/2914",0.0488159908670466,0.0984375261378398,0.052063606726362,"MAPK14/MAPKAPK2",2
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","2/81","13/2914",0.0488159908670466,0.0984375261378398,0.052063606726362,"RELA/NFKB1",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/81","13/2914",0.0488159908670466,0.0984375261378398,0.052063606726362,"TP53/EP300",2
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","2/81","13/2914",0.0488159908670466,0.0984375261378398,0.052063606726362,"SP1/TBP",2
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","2/81","13/2914",0.0488159908670466,0.0984375261378398,0.052063606726362,"CREBBP/EP300",2
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","3/81","30/2914",0.0490103503710108,0.0985043555154198,0.0520989527835884,"TP53/CREBBP/BCL6",3
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","6/81","97/2914",0.0507670480764279,0.101700545490811,0.053789417634041,"AKT1/AKT2/AKT3/GSK3B/PIK3CA/PIK3R1",6
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","7/81","124/2914",0.0545520927158782,0.108925910618959,0.0576109131880791,"TP53/AR/CDK1/EP300/SMAD3/YY1/SMAD4",7
"R-HSA-373753","R-HSA-373753","Nephrin family interactions","2/81","14/2914",0.0559457614150196,0.109210416052962,0.0577613881096722,"PIK3CA/PIK3R1",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","2/81","14/2914",0.0559457614150196,0.109210416052962,0.0577613881096722,"CTNNB1/TCF7L2",2
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","2/81","14/2914",0.0559457614150196,0.109210416052962,0.0577613881096722,"PIK3CA/PIK3R1",2
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","2/81","14/2914",0.0559457614150196,0.109210416052962,0.0577613881096722,"PIK3CA/PIK3R1",2
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","2/81","14/2914",0.0559457614150196,0.109210416052962,0.0577613881096722,"JAK2/STAT1",2
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","2/81","14/2914",0.0559457614150196,0.109210416052962,0.0577613881096722,"CREBBP/EP300",2
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","2/81","14/2914",0.0559457614150196,0.109210416052962,0.0577613881096722,"SMAD3/SMAD4",2
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","3/81","32/2914",0.0575702615903298,0.111314651366112,0.0588743181486718,"RPS6KA5/MAPK1/MAPK3",3
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","3/81","32/2914",0.0575702615903298,0.111314651366112,0.0588743181486718,"JAK2/STAT1/STAT3",3
"R-HSA-8853659","R-HSA-8853659","RET signaling","3/81","32/2914",0.0575702615903298,0.111314651366112,0.0588743181486718,"PRKACA/PIK3CA/PIK3R1",3
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","5/81","76/2914",0.0582219110371783,0.112219519380807,0.0593529028338494,"HDAC1/HDAC2/HDAC3/RELA/NFKB1",5
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","8/81","153/2914",0.0597094007651982,0.114724666250114,0.0606778749914461,"AKT1/MAPK14/PIK3CA/PIK3R1/PRKCZ/YWHAZ/MAPK1/MAPK3",8
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","5/81","77/2914",0.0609561994752931,0.11675309680064,0.0617507118921465,"PRKACA/RPS6KA1/RPS6KA2/MAPK1/MAPK3",5
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","13/81","296/2914",0.0619538635423697,0.118293158201212,0.0625652503536431,"AKT1/AKT2/AKT3/PAK1/PPP2CA/PPP2CB/PRKACA/FBXW7/RELA/PIK3CA/PIK3R1/YWHAZ/NFKB1",13
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/81","15/2914",0.0634148106994133,0.118490670756396,0.0626697147423785,"SMAD3/SMAD4",2
"R-HSA-1660499","R-HSA-1660499","Synthesis of PIPs at the plasma membrane","2/81","15/2914",0.0634148106994133,0.118490670756396,0.0626697147423785,"PIK3CA/PIK3R1",2
"R-HSA-2730905","R-HSA-2730905","Role of LAT2/NTAL/LAB on calcium mobilization","2/81","15/2914",0.0634148106994133,0.118490670756396,0.0626697147423785,"PIK3CA/PIK3R1",2
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","2/81","15/2914",0.0634148106994133,0.118490670756396,0.0626697147423785,"AR/NR3C1",2
"R-HSA-392517","R-HSA-392517","Rap1 signalling","2/81","15/2914",0.0634148106994133,0.118490670756396,0.0626697147423785,"PRKACA/YWHAZ",2
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","2/81","15/2914",0.0634148106994133,0.118490670756396,0.0626697147423785,"TP53/CREBBP",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/81","15/2914",0.0634148106994133,0.118490670756396,0.0626697147423785,"STAT3/SMAD3",2
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","4/81","55/2914",0.0648087421291961,0.120726040978472,0.063852002033579,"PPP2CA/PPP2CB/PRKACA/STK11",4
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","3/81","34/2914",0.066789756120498,0.123662245423104,0.0654049605390523,"PPP2CA/PPP2CB/CDK1",3
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","3/81","34/2914",0.066789756120498,0.123662245423104,0.0654049605390523,"PAK1/PRKACA/CDK1",3
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","16/81","393/2914",0.0706104084681951,0.127574090329986,0.0674739352766054,"HDAC1/HDAC2/PML/PPARGC1A/TP53/CREBBP/FBXW7/RELA/AR/CDK1/EP300/UBE2I/NR3C1/SMAD3/YY1/SMAD4",16
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/81","16/2914",0.0711992877291737,0.127574090329986,0.0674739352766054,"MAPK1/MAPK3",2
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","2/81","16/2914",0.0711992877291737,0.127574090329986,0.0674739352766054,"PIK3CA/PIK3R1",2
"R-HSA-1810476","R-HSA-1810476","RIP-mediated NFkB activation via ZBP1","2/81","16/2914",0.0711992877291737,0.127574090329986,0.0674739352766054,"RELA/NFKB1",2
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","2/81","16/2914",0.0711992877291737,0.127574090329986,0.0674739352766054,"PIK3CA/PIK3R1",2
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","2/81","16/2914",0.0711992877291737,0.127574090329986,0.0674739352766054,"TP53/UBE2I",2
"R-HSA-5205647","R-HSA-5205647","Mitophagy","2/81","16/2914",0.0711992877291737,0.127574090329986,0.0674739352766054,"CSNK2A1/CSNK2A2",2
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","2/81","16/2914",0.0711992877291737,0.127574090329986,0.0674739352766054,"PIK3CA/PIK3R1",2
"R-HSA-622312","R-HSA-622312","Inflammasomes","2/81","16/2914",0.0711992877291737,0.127574090329986,0.0674739352766054,"RELA/NFKB1",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/81","16/2914",0.0711992877291737,0.127574090329986,0.0674739352766054,"TP53/CDK1",2
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","2/81","16/2914",0.0711992877291737,0.127574090329986,0.0674739352766054,"PIK3CA/PIK3R1",2
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","9/81","188/2914",0.0741165195942441,0.1324128464096,0.0700331533254323,"AKT2/PPP2CA/PPP2CB/DAB2IP/JAK2/PIK3CA/PIK3R1/MAPK1/MAPK3",9
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","5/81","82/2914",0.0757127686095109,0.134870267114901,0.071332883115298,"HMGB1/RELA/STAT3/SMAD3/NFKB1",5
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","2/81","17/2914",0.079276376570911,0.139590392175293,0.0738293572190799,"PIK3CA/PIK3R1",2
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","2/81","17/2914",0.079276376570911,0.139590392175293,0.0738293572190799,"PIK3CA/PIK3R1",2
"R-HSA-210993","R-HSA-210993","Tie2 Signaling","2/81","17/2914",0.079276376570911,0.139590392175293,0.0738293572190799,"PIK3CA/PIK3R1",2
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","2/81","17/2914",0.079276376570911,0.139590392175293,0.0738293572190799,"PML/UBE2I",2
"R-HSA-111885","R-HSA-111885","Opioid Signalling","4/81","59/2914",0.0796665893002231,0.139874385236886,0.0739795611469101,"PPP2CA/PPP2CB/PRKACA/MAPK1",4
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","6/81","109/2914",0.0802181716203693,0.1404392632093,0.074278325101654,"AKT1/PPP2CA/SET/MAPK14/YWHAZ/MAPKAPK2",6
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","3/81","37/2914",0.0817958535206097,0.142792190003121,0.0755227880626381,"CREBBP/EP300/STAT1",3
"R-HSA-1483255","R-HSA-1483255","PI Metabolism","2/81","18/2914",0.0876242583894356,0.151666917495595,0.0802166313569606,"PIK3CA/PIK3R1",2
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","2/81","18/2914",0.0876242583894356,0.151666917495595,0.0802166313569606,"PRKACA/GSK3B",2
"R-HSA-5654710","R-HSA-5654710","PI-3K cascade:FGFR3","2/81","18/2914",0.0876242583894356,0.151666917495595,0.0802166313569606,"PIK3CA/PIK3R1",2
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","5/81","86/2914",0.0888040152769406,0.153274726932799,0.0810670017544477,"HDAC1/SP1/PRKCZ/SMAD3/SMAD4",5
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","4/81","62/2914",0.0918335557540617,0.158057190326005,0.0835964466019183,"TP53/CDK1/YWHAQ/YWHAZ",4
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","6/81","114/2914",0.0948459422486805,0.161515625487767,0.0854256129291831,"PPP2CA/PPP2CB/TP53/CDK1/YWHAQ/YWHAZ",6
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","5/81","88/2914",0.0957690708689038,0.161515625487767,0.0854256129291831,"PRKACA/RPS6KA1/RPS6KA2/MAPK1/MAPK3",5
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","2/81","19/2914",0.0962220747586694,0.161515625487767,0.0854256129291831,"CREBBP/BHLHE40",2
"R-HSA-1606322","R-HSA-1606322","ZBP1(DAI) mediated induction of type I IFNs","2/81","19/2914",0.0962220747586694,0.161515625487767,0.0854256129291831,"RELA/NFKB1",2
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","2/81","19/2914",0.0962220747586694,0.161515625487767,0.0854256129291831,"CREBBP/EP300",2
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","2/81","19/2914",0.0962220747586694,0.161515625487767,0.0854256129291831,"PRKACA/GSK3B",2
"R-HSA-5654720","R-HSA-5654720","PI-3K cascade:FGFR4","2/81","19/2914",0.0962220747586694,0.161515625487767,0.0854256129291831,"PIK3CA/PIK3R1",2
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","2/81","19/2914",0.0962220747586694,0.161515625487767,0.0854256129291831,"CSNK2A1/CSNK2A2",2
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","2/81","19/2914",0.0962220747586694,0.161515625487767,0.0854256129291831,"HDAC3/EP300",2
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","9/81","202/2914",0.10490002341416,0.173474281448593,0.091750545963852,"PAK1/PPP2CA/PPP2CB/PRKACA/CDK1/DAB2IP/JAK2/MAPK1/MAPK3",9
"R-HSA-167044","R-HSA-167044","Signalling to RAS","2/81","20/2914",0.105049892202912,0.173474281448593,0.091750545963852,"MAPK14/MAPKAPK2",2
"R-HSA-5260271","R-HSA-5260271","Diseases of Immune System","2/81","20/2914",0.105049892202912,0.173474281448593,0.091750545963852,"RELA/NFKB1",2
"R-HSA-5602358","R-HSA-5602358","Diseases associated with the TLR signaling cascade","2/81","20/2914",0.105049892202912,0.173474281448593,0.091750545963852,"RELA/NFKB1",2
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","2/81","20/2914",0.105049892202912,0.173474281448593,0.091750545963852,"HDAC1/EP300",2
"R-HSA-912631","R-HSA-912631","Regulation of signaling by CBL","2/81","20/2914",0.105049892202912,0.173474281448593,0.091750545963852,"PIK3CA/PIK3R1",2
"R-HSA-109704","R-HSA-109704","PI3K Cascade","3/81","42/2914",0.109685351865098,0.178238696780784,0.0942704451920074,"AKT2/PIK3CA/PIK3R1",3
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","3/81","42/2914",0.109685351865098,0.178238696780784,0.0942704451920074,"PPP2CA/PPP2CB/MAPK14",3
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","3/81","42/2914",0.109685351865098,0.178238696780784,0.0942704451920074,"JAK2/MAPK1/MAPK3",3
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","3/81","42/2914",0.109685351865098,0.178238696780784,0.0942704451920074,"JAK2/MAPK1/MAPK3",3
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","3/81","42/2914",0.109685351865098,0.178238696780784,0.0942704451920074,"JAK2/MAPK1/MAPK3",3
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","3/81","42/2914",0.109685351865098,0.178238696780784,0.0942704451920074,"JAK2/MAPK1/MAPK3",3
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","2/81","21/2914",0.114088667929658,0.184413164298998,0.0975361210092036,"MAPK14/MAPKAPK2",2
"R-HSA-5654689","R-HSA-5654689","PI-3K cascade:FGFR1","2/81","21/2914",0.114088667929658,0.184413164298998,0.0975361210092036,"PIK3CA/PIK3R1",2
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","3/81","43/2914",0.115657423077198,0.186455634565087,0.0986163835153446,"PAK1/MAPK1/MAPK3",3
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","3/81","44/2914",0.121750649542881,0.195762228607107,0.103538641024002,"PPP2CA/PPP2CB/PRKACA",3
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","2/81","22/2914",0.123320216716321,0.196220448993938,0.10378099378265,"PIK3R1/STAT3",2
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","2/81","22/2914",0.123320216716321,0.196220448993938,0.10378099378265,"PIK3CA/PIK3R1",2
"R-HSA-5655332","R-HSA-5655332","Signaling by FGFR3 in disease","2/81","22/2914",0.123320216716321,0.196220448993938,0.10378099378265,"PIK3CA/PIK3R1",2
"R-HSA-8853338","R-HSA-8853338","Signaling by FGFR3 point mutants in cancer","2/81","22/2914",0.123320216716321,0.196220448993938,0.10378099378265,"PIK3CA/PIK3R1",2
"R-HSA-913531","R-HSA-913531","Interferon Signaling","5/81","97/2914",0.130412195475574,0.206965847884612,0.109464235163366,"PML/JAK2/STAT1/MAPK3/IRF1",5
"R-HSA-5654695","R-HSA-5654695","PI-3K cascade:FGFR2","2/81","23/2914",0.132727178914362,0.210094057815221,0.111118745368719,"PIK3CA/PIK3R1",2
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","3/81","46/2914",0.134282588864426,0.211460468546814,0.111841439992888,"AKT2/PIK3CA/PIK3R1",3
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","3/81","46/2914",0.134282588864426,0.211460468546814,0.111841439992888,"JAK2/MAPK1/MAPK3",3
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","3/81","47/2914",0.140712245502347,0.220449184620343,0.116595571846749,"AKT1/STAT3/NR3C1",3
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","3/81","47/2914",0.140712245502347,0.220449184620343,0.116595571846749,"AKT1/STAT3/NR3C1",3
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","2/81","24/2914",0.14229298953542,0.220662478695791,0.116708383081416,"RELA/NFKB1",2
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","2/81","24/2914",0.14229298953542,0.220662478695791,0.116708383081416,"PIK3CA/PIK3R1",2
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","2/81","24/2914",0.14229298953542,0.220662478695791,0.116708383081416,"PIK3CA/PIK3R1",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/81","24/2914",0.14229298953542,0.220662478695791,0.116708383081416,"TP53/RB1",2
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","3/81","48/2914",0.147244964031732,0.227763729173134,0.120464234397713,"RELA/MAPK14/NFKB1",3
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/81","25/2914",0.152001848385112,0.231603813873575,0.122495255162697,"PRKACA/CDK1",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/81","25/2914",0.152001848385112,0.231603813873575,0.122495255162697,"PRKACA/CDK1",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/81","25/2914",0.152001848385112,0.231603813873575,0.122495255162697,"MAPK1/MAPK3",2
"R-HSA-5654708","R-HSA-5654708","Downstream signaling of activated FGFR3","2/81","25/2914",0.152001848385112,0.231603813873575,0.122495255162697,"PIK3CA/PIK3R1",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/81","25/2914",0.152001848385112,0.231603813873575,0.122495255162697,"MAPK1/MAPK3",2
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","2/81","25/2914",0.152001848385112,0.231603813873575,0.122495255162697,"PIK3CA/PIK3R1",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","3/81","49/2914",0.153876191651474,0.233876500246395,0.123697278965705,"JAK2/MAPK1/MAPK3",3
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","3/81","50/2914",0.160601380745344,0.242361373357976,0.128184928281331,"AKT2/PIK3CA/PIK3R1",3
"R-HSA-111996","R-HSA-111996","Ca-dependent events","2/81","26/2914",0.161838691211218,0.242361373357976,0.128184928281331,"PRKACA/MAPK1",2
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/81","26/2914",0.161838691211218,0.242361373357976,0.128184928281331,"PRKACA/CDK1",2
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","2/81","26/2914",0.161838691211218,0.242361373357976,0.128184928281331,"PIK3CA/PIK3R1",2
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","2/81","26/2914",0.161838691211218,0.242361373357976,0.128184928281331,"CTNNB1/HMGB1",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/81","26/2914",0.161838691211218,0.242361373357976,0.128184928281331,"PRKACA/CDK1",2
"R-HSA-112316","R-HSA-112316","Neuronal System","5/81","105/2914",0.165366834113021,0.247039451450014,0.130659163743913,"PRKACA/RPS6KA1/RPS6KA2/MAPK1/MAPK3",5
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","3/81","51/2914",0.167415996381807,0.248883634523806,0.131634552155756,"AKT2/PIK3CA/PIK3R1",3
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","3/81","51/2914",0.167415996381807,0.248883634523806,0.131634552155756,"AKT2/PIK3CA/PIK3R1",3
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","5/81","106/2914",0.169983808648765,0.252087638554358,0.133329149859916,"HDAC1/HDAC2/HDAC3/RELA/NFKB1",5
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/81","27/2914",0.171789161833958,0.252923320194092,0.133771141871972,"PRKACA/CDK1",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/81","27/2914",0.171789161833958,0.252923320194092,0.133771141871972,"PRKACA/CDK1",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/81","27/2914",0.171789161833958,0.252923320194092,0.133771141871972,"TP53/CDK1",2
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","4/81","80/2914",0.180877029097933,0.264533301366044,0.139911660813809,"TP53/AR/SMAD3/SMAD4",4
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","2/81","28/2914",0.181839585227068,0.264533301366044,0.139911660813809,"SMAD3/SMAD4",2
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/81","28/2914",0.181839585227068,0.264533301366044,0.139911660813809,"PRKACA/CDK1",2
"R-HSA-5654687","R-HSA-5654687","Downstream signaling of activated FGFR1","2/81","28/2914",0.181839585227068,0.264533301366044,0.139911660813809,"PIK3CA/PIK3R1",2
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","2/81","28/2914",0.181839585227068,0.264533301366044,0.139911660813809,"CREBBP/EP300",2
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","2/81","29/2914",0.191976941519321,0.277957135706884,0.147011526681046,"PPP2CA/PPP2CB",2
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","2/81","29/2914",0.191976941519321,0.277957135706884,0.147011526681046,"PPP2CA/PPP2CB",2
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","3/81","55/2914",0.195478846901346,0.282358334413056,0.149339320638829,"EP300/UBE2I/YY1",3
"R-HSA-5654696","R-HSA-5654696","Downstream signaling of activated FGFR2","2/81","30/2914",0.202188840887057,0.29136174948583,0.154101226793263,"PIK3CA/PIK3R1",2
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","6/81","144/2914",0.208902316842862,0.300327801390562,0.158843371568443,"AKT1/AKT2/AKT3/YWHAQ/YWHAZ/CUX1",6
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","3/81","57/2914",0.209930947587129,0.300392995259334,0.158877852605075,"CTNNB1/PIK3CA/PIK3R1",3
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","3/81","57/2914",0.209930947587129,0.300392995259334,0.158877852605075,"HMGB1/RELA/NFKB1",3
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","2/81","31/2914",0.212463499309208,0.303306537565248,0.160418825105575,"RELA/NFKB1",2
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","7/81","177/2914",0.218860377073679,0.311710234014028,0.164863540084945,"PPP2CA/PPP2CB/CDK1/DAB2IP/JAK2/MAPK1/MAPK3",7
"R-HSA-5655253","R-HSA-5655253","Signaling by FGFR2 in disease","2/81","32/2914",0.222789715157133,0.31583414376104,0.167044675914617,"PIK3CA/PIK3R1",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/81","32/2914",0.222789715157133,0.31583414376104,0.167044675914617,"MAPK1/MAPK3",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","2/81","34/2914",0.243554789746964,0.339753371085377,0.179695555040418,"PRKACA/MAPK1",2
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","2/81","34/2914",0.243554789746964,0.339753371085377,0.179695555040418,"PRKACA/MAPK1",2
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","2/81","34/2914",0.243554789746964,0.339753371085377,0.179695555040418,"STAT1/MAPK3",2
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","2/81","34/2914",0.243554789746964,0.339753371085377,0.179695555040418,"CREBBP/EP300",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/81","34/2914",0.243554789746964,0.339753371085377,0.179695555040418,"MAPK1/MAPK3",2
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","2/81","34/2914",0.243554789746964,0.339753371085377,0.179695555040418,"TP53/UBE2I",2
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","2/81","34/2914",0.243554789746964,0.339753371085377,0.179695555040418,"TP53/FOS",2
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","1/81","10/2914",0.245988286706607,0.341588279949403,0.180666038322795,"UBE2I",1
"R-HSA-211945","R-HSA-211945","Phase I - Functionalization of compounds","1/81","10/2914",0.245988286706607,0.341588279949403,0.180666038322795,"ARNT",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","3/81","62/2914",0.247013260397222,0.342233791616106,0.181007449437755,"PIK3CA/PIK3R1/STAT3",3
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","2/81","35/2914",0.253973957659164,0.348714804785953,0.184435257247459,"STAT1/MAPK3",2
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","2/81","35/2914",0.253973957659164,0.348714804785953,0.184435257247459,"PAK1/MAPK14",2
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","2/81","35/2914",0.253973957659164,0.348714804785953,0.184435257247459,"PRKACA/GSK3B",2
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","2/81","35/2914",0.253973957659164,0.348714804785953,0.184435257247459,"TP53/UBE2I",2
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","3/81","63/2914",0.254560043368473,0.348735844166226,0.184446384975504,"RELA/PIK3R1/NFKB1",3
"R-HSA-163615","R-HSA-163615","PKA activation","1/81","11/2914",0.267019605155907,0.356220477620653,0.188405007545078,"PRKACA",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/81","11/2914",0.267019605155907,0.356220477620653,0.188405007545078,"EP300",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/81","11/2914",0.267019605155907,0.356220477620653,0.188405007545078,"TP53",1
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","1/81","11/2914",0.267019605155907,0.356220477620653,0.188405007545078,"PAK1",1
"R-HSA-5686938","R-HSA-5686938","Regulation of TLR by endogenous ligand","1/81","11/2914",0.267019605155907,0.356220477620653,0.188405007545078,"HMGB1",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/81","11/2914",0.267019605155907,0.356220477620653,0.188405007545078,"TP53",1
"R-HSA-73772","R-HSA-73772","RNA Polymerase I Promoter Escape","1/81","11/2914",0.267019605155907,0.356220477620653,0.188405007545078,"TBP",1
"R-HSA-73863","R-HSA-73863","RNA Polymerase I Transcription Termination","1/81","11/2914",0.267019605155907,0.356220477620653,0.188405007545078,"TBP",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/81","11/2914",0.267019605155907,0.356220477620653,0.188405007545078,"GSK3B",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/81","11/2914",0.267019605155907,0.356220477620653,0.188405007545078,"YY1",1
"R-HSA-8978868","R-HSA-8978868","Fatty acid metabolism","1/81","11/2914",0.267019605155907,0.356220477620653,0.188405007545078,"MAPKAPK2",1
"R-HSA-9013700","R-HSA-9013700","NOTCH4 Activation and Transmission of Signal to the Nucleus","1/81","11/2914",0.267019605155907,0.356220477620653,0.188405007545078,"YWHAZ",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/81","37/2914",0.274840083167568,0.365854664085804,0.193500528683507,"PRKACA/CDK1",2
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","6/81","160/2914",0.283883233284856,0.374509582420972,0.198078114916424,"AKT1/AKT2/AKT3/YWHAQ/YWHAZ/CUX1",6
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","2/81","38/2914",0.2852702719165,0.374509582420972,0.198078114916424,"RELA/NFKB1",2
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","2/81","38/2914",0.2852702719165,0.374509582420972,0.198078114916424,"PML/UBE2I",2
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","2/81","38/2914",0.2852702719165,0.374509582420972,0.198078114916424,"PAK1/GSK3B",2
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/81","12/2914",0.287471348863234,0.374509582420972,0.198078114916424,"CDK1",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/81","12/2914",0.287471348863234,0.374509582420972,0.198078114916424,"PAK1",1
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","1/81","12/2914",0.287471348863234,0.374509582420972,0.198078114916424,"PAK1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/81","12/2914",0.287471348863234,0.374509582420972,0.198078114916424,"CTNNB1",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/81","12/2914",0.287471348863234,0.374509582420972,0.198078114916424,"PRKACA",1
"R-HSA-8963898","R-HSA-8963898","Plasma lipoprotein assembly","1/81","12/2914",0.287471348863234,0.374509582420972,0.198078114916424,"PRKACA",1
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","2/81","39/2914",0.295688110518997,0.384394543674696,0.20330627083837,"RELA/NFKB1",2
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","2/81","40/2914",0.30608630541667,0.393703416072834,0.208229733369558,"CTNNB1/TCF7L2",2
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/81","13/2914",0.307359295362917,0.393703416072834,0.208229733369558,"PRKACA",1
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","1/81","13/2914",0.307359295362917,0.393703416072834,0.208229733369558,"UBE2I",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/81","13/2914",0.307359295362917,0.393703416072834,0.208229733369558,"PAK1",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/81","13/2914",0.307359295362917,0.393703416072834,0.208229733369558,"CTNNB1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/81","13/2914",0.307359295362917,0.393703416072834,0.208229733369558,"EP300",1
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","1/81","13/2914",0.307359295362917,0.393703416072834,0.208229733369558,"PAK1",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","6/81","165/2914",0.308558367588311,0.394412474051168,0.208604754128191,"RPS6KA1/RPS6KA2/PIK3CA/PIK3R1/MAPK1/MAPK3",6
"R-HSA-211859","R-HSA-211859","Biological oxidations","1/81","14/2914",0.326698797974293,0.405838865791922,0.214648172621449,"ARNT",1
"R-HSA-2173791","R-HSA-2173791","TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)","1/81","14/2914",0.326698797974293,0.405838865791922,0.214648172621449,"PRKCZ",1
"R-HSA-3214858","R-HSA-3214858","RMTs methylate histone arginines","1/81","14/2914",0.326698797974293,0.405838865791922,0.214648172621449,"JAK2",1
"R-HSA-445355","R-HSA-445355","Smooth Muscle Contraction","1/81","14/2914",0.326698797974293,0.405838865791922,0.214648172621449,"PAK1",1
"R-HSA-5684264","R-HSA-5684264","MAP3K8 (TPL2)-dependent MAPK1/3 activation","1/81","14/2914",0.326698797974293,0.405838865791922,0.214648172621449,"NFKB1",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/81","14/2914",0.326698797974293,0.405838865791922,0.214648172621449,"E2F1",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/81","14/2914",0.326698797974293,0.405838865791922,0.214648172621449,"STAT3",1
"R-HSA-9027284","R-HSA-9027284","Erythropoietin activates RAS","1/81","14/2914",0.326698797974293,0.405838865791922,0.214648172621449,"JAK2",1
"R-HSA-927802","R-HSA-927802","Nonsense-Mediated Decay (NMD)","1/81","14/2914",0.326698797974293,0.405838865791922,0.214648172621449,"PPP2CA",1
"R-HSA-975957","R-HSA-975957","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)","1/81","14/2914",0.326698797974293,0.405838865791922,0.214648172621449,"PPP2CA",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","2/81","42/2914",0.32679659896829,0.405838865791922,0.214648172621449,"CTNNB1/TCF7L2",2
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/81","42/2914",0.32679659896829,0.405838865791922,0.214648172621449,"PRKACA/CDK1",2
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","2/81","42/2914",0.32679659896829,0.405838865791922,0.214648172621449,"PPP2CA/PPP2CB",2
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","2/81","42/2914",0.32679659896829,0.405838865791922,0.214648172621449,"STAT1/IRF1",2
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","6/81","171/2914",0.338669176568579,0.419729953110348,0.221995168584507,"PPP2CA/PPP2CB/DAB2IP/JAK2/MAPK1/MAPK3",6
"R-HSA-1170546","R-HSA-1170546","Prolactin receptor signaling","1/81","15/2914",0.345504797065356,0.424755394380146,0.224653124428814,"JAK2",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/81","15/2914",0.345504797065356,0.424755394380146,0.224653124428814,"CDK1",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/81","15/2914",0.345504797065356,0.424755394380146,0.224653124428814,"TP53",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/81","15/2914",0.345504797065356,0.424755394380146,0.224653124428814,"CTNNB1",1
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","2/81","44/2914",0.347350614840125,0.425313077489612,0.224948083020606,"PIK3CA/PIK3R1",2
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","2/81","44/2914",0.347350614840125,0.425313077489612,0.224948083020606,"PIK3CA/PIK3R1",2
"R-HSA-166208","R-HSA-166208","mTORC1-mediated signalling","1/81","16/2914",0.363791831021101,0.441025414194232,0.233258337768334,"RPS6KB1",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/81","16/2914",0.363791831021101,0.441025414194232,0.233258337768334,"PAK1",1
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","1/81","16/2914",0.363791831021101,0.441025414194232,0.233258337768334,"PAK1",1
"R-HSA-6788467","R-HSA-6788467","IL-6-type cytokine receptor ligand interactions","1/81","16/2914",0.363791831021101,0.441025414194232,0.233258337768334,"JAK2",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/81","16/2914",0.363791831021101,0.441025414194232,0.233258337768334,"EP300",1
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","2/81","46/2914",0.367703541238573,0.444884878607461,0.235299608463245,"UBE2I/YY1",2
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","2/81","47/2914",0.377792043271294,0.450080584306389,0.238047617162652,"PPP2CA/PPP2CB",2
"R-HSA-163359","R-HSA-163359","Glucagon signaling in metabolic regulation","1/81","17/2914",0.381574046924238,0.450080584306389,0.238047617162652,"PRKACA",1
"R-HSA-167161","R-HSA-167161","HIV Transcription Initiation","1/81","17/2914",0.381574046924238,0.450080584306389,0.238047617162652,"TBP",1
"R-HSA-167162","R-HSA-167162","RNA Polymerase II HIV Promoter Escape","1/81","17/2914",0.381574046924238,0.450080584306389,0.238047617162652,"TBP",1
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/81","17/2914",0.381574046924238,0.450080584306389,0.238047617162652,"CDK1",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/81","17/2914",0.381574046924238,0.450080584306389,0.238047617162652,"MAPK14",1
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","1/81","17/2914",0.381574046924238,0.450080584306389,0.238047617162652,"UBE2I",1
"R-HSA-5607761","R-HSA-5607761","Dectin-1 mediated noncanonical NF-kB signaling","1/81","17/2914",0.381574046924238,0.450080584306389,0.238047617162652,"RELA",1
"R-HSA-5696394","R-HSA-5696394","DNA Damage Recognition in GG-NER","1/81","17/2914",0.381574046924238,0.450080584306389,0.238047617162652,"YY1",1
"R-HSA-73776","R-HSA-73776","RNA Polymerase II Promoter Escape","1/81","17/2914",0.381574046924238,0.450080584306389,0.238047617162652,"TBP",1
"R-HSA-73779","R-HSA-73779","RNA Polymerase II Transcription Pre-Initiation And Promoter Opening","1/81","17/2914",0.381574046924238,0.450080584306389,0.238047617162652,"TBP",1
"R-HSA-75953","R-HSA-75953","RNA Polymerase II Transcription Initiation","1/81","17/2914",0.381574046924238,0.450080584306389,0.238047617162652,"TBP",1
"R-HSA-76042","R-HSA-76042","RNA Polymerase II Transcription Initiation And Promoter Clearance","1/81","17/2914",0.381574046924238,0.450080584306389,0.238047617162652,"TBP",1
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/81","18/2914",0.398865210955697,0.465978286604074,0.246455911770955,"PAK1",1
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","1/81","18/2914",0.398865210955697,0.465978286604074,0.246455911770955,"STK11",1
"R-HSA-5610780","R-HSA-5610780","Degradation of GLI1 by the proteasome","1/81","18/2914",0.398865210955697,0.465978286604074,0.246455911770955,"PRKACA",1
"R-HSA-5658442","R-HSA-5658442","Regulation of RAS by GAPs","1/81","18/2914",0.398865210955697,0.465978286604074,0.246455911770955,"DAB2IP",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/81","18/2914",0.398865210955697,0.465978286604074,0.246455911770955,"E2F1",1
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/81","19/2914",0.415678718522199,0.482851135013429,0.25537996114932,"CDK1",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/81","19/2914",0.415678718522199,0.482851135013429,0.25537996114932,"CTNNB1",1
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","1/81","19/2914",0.415678718522199,0.482851135013429,0.25537996114932,"PRKCZ",1
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","1/81","20/2914",0.432027604117951,0.498995966192945,0.263918962221094,"MAPK9",1
"R-HSA-5578775","R-HSA-5578775","Ion homeostasis","1/81","20/2914",0.432027604117951,0.498995966192945,0.263918962221094,"PRKACA",1
"R-HSA-6811442","R-HSA-6811442","Intra-Golgi and retrograde Golgi-to-ER traffic","1/81","20/2914",0.432027604117951,0.498995966192945,0.263918962221094,"CUX1",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","2/81","53/2914",0.43682674761425,0.501693877429148,0.265345887450682,"CSNK2A1/CSNK2A2",2
"R-HSA-397014","R-HSA-397014","Muscle contraction","2/81","53/2914",0.43682674761425,0.501693877429148,0.265345887450682,"PAK1/PRKACA",2
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","2/81","53/2914",0.43682674761425,0.501693877429148,0.265345887450682,"RELA/NFKB1",2
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","13/81","436/2914",0.438535776522536,0.502711743818517,0.265884236975252,"AKT1/AKT2/AKT3/PAK1/PPP2CA/PPP2CB/PRKACA/RPS6KA1/RPS6KA2/PIK3CA/PIK3R1/MAPK1/MAPK3",13
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/81","21/2914",0.447924550927365,0.511554954423589,0.270561410988099,"CTNNB1",1
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","1/81","21/2914",0.447924550927365,0.511554954423589,0.270561410988099,"UBE2I",1
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","2/81","55/2914",0.455851592092187,0.519636796209563,0.274835897039083,"PRKACA/GSK3B",2
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","4/81","125/2914",0.461468948030057,0.520452832733891,0.275267498749771,"HMGB1/MAPK14/MAPK1/NFKB1",4
"R-HSA-1500620","R-HSA-1500620","Meiosis","1/81","22/2914",0.463381900175511,0.520452832733891,0.275267498749771,"UBE2I",1
"R-HSA-167172","R-HSA-167172","Transcription of the HIV genome","1/81","22/2914",0.463381900175511,0.520452832733891,0.275267498749771,"TBP",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/81","22/2914",0.463381900175511,0.520452832733891,0.275267498749771,"SMAD3",1
"R-HSA-432040","R-HSA-432040","Vasopressin regulates renal water homeostasis via Aquaporins","1/81","22/2914",0.463381900175511,0.520452832733891,0.275267498749771,"PRKACA",1
"R-HSA-445717","R-HSA-445717","Aquaporin-mediated transport","1/81","22/2914",0.463381900175511,0.520452832733891,0.275267498749771,"PRKACA",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/81","22/2914",0.463381900175511,0.520452832733891,0.275267498749771,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/81","22/2914",0.463381900175511,0.520452832733891,0.275267498749771,"TP53",1
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","2/81","56/2914",0.465228559325363,0.521568164674856,0.27585739780374,"PPP2CA/PPP2CB",2
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/81","23/2914",0.478411660232835,0.532439935158948,0.281607477119126,"SMAD4",1
"R-HSA-392518","R-HSA-392518","Signal amplification","1/81","23/2914",0.478411660232835,0.532439935158948,0.281607477119126,"MAPK14",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/81","23/2914",0.478411660232835,0.532439935158948,0.281607477119126,"E2F1",1
"R-HSA-9020591","R-HSA-9020591","Interleukin-12 signaling","1/81","23/2914",0.478411660232835,0.532439935158948,0.281607477119126,"JAK2",1
"R-HSA-1474165","R-HSA-1474165","Reproduction","1/81","24/2914",0.493025515480549,0.545722083258361,0.288632405134494,"UBE2I",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/81","24/2914",0.493025515480549,0.545722083258361,0.288632405134494,"TP53",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/81","24/2914",0.493025515480549,0.545722083258361,0.288632405134494,"STAT1",1
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","2/81","60/2914",0.50178225088642,0.55441040739892,0.293227659697594,"PPP2CA/PPP2CB",2
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","1/81","25/2914",0.507234834942859,0.556410204937319,0.294285352598427,"PRKACA",1
"R-HSA-111997","R-HSA-111997","CaM pathway","1/81","25/2914",0.507234834942859,0.556410204937319,0.294285352598427,"PRKACA",1
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/81","25/2914",0.507234834942859,0.556410204937319,0.294285352598427,"AKT1",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/81","25/2914",0.507234834942859,0.556410204937319,0.294285352598427,"AKT1",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","2/81","61/2914",0.510673019899138,0.558177486866499,0.295220067995547,"PPP2CA/PPP2CB",2
"R-HSA-9612973","R-HSA-9612973","Autophagy","2/81","61/2914",0.510673019899138,0.558177486866499,0.295220067995547,"CSNK2A1/CSNK2A2",2
"R-HSA-674695","R-HSA-674695","RNA Polymerase II Pre-transcription Events","1/81","26/2914",0.521050680692125,0.568503510540872,0.300681501827974,"TBP",1
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/81","27/2914",0.534483816032823,0.579024134035559,0.306245859503689,"CDK1",1
"R-HSA-5689603","R-HSA-5689603","UCH proteinases","1/81","27/2914",0.534483816032823,0.579024134035559,0.306245859503689,"YY1",1
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","1/81","27/2914",0.534483816032823,0.579024134035559,0.306245859503689,"MYB",1
"R-HSA-983695","R-HSA-983695","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","1/81","27/2914",0.534483816032823,0.579024134035559,0.306245859503689,"PIK3R1",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","2/81","64/2914",0.536727815381007,0.580426009199637,0.306987311265895,"PAK1/PRKACA",2
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/81","28/2914",0.547544713470073,0.58899616184897,0.311520064928303,"CDK1",1
"R-HSA-381676","R-HSA-381676","Glucagon-like Peptide-1 (GLP1) regulates insulin secretion","1/81","28/2914",0.547544713470073,0.58899616184897,0.311520064928303,"PRKACA",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/81","28/2914",0.547544713470073,0.58899616184897,0.311520064928303,"EP300",1
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/81","29/2914",0.560243562468315,0.600541783628316,0.317626544187946,"CDK1",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/81","29/2914",0.560243562468315,0.600541783628316,0.317626544187946,"EP300",1
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","1/81","30/2914",0.5725902770056,0.610563105149077,0.322926821053953,"PRKACA",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/81","30/2914",0.5725902770056,0.610563105149077,0.322926821053953,"CDK1",1
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","1/81","30/2914",0.5725902770056,0.610563105149077,0.322926821053953,"UBE2I",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","2/81","69/2914",0.578035808033709,0.615295955938321,0.325430025795615,"PIK3CA/PIK3R1",2
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","1/81","31/2914",0.584594502928813,0.620116738349834,0.327979737571538,"PRKACA",1
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/81","31/2914",0.584594502928813,0.620116738349834,0.327979737571538,"AKT1",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/81","32/2914",0.596265625114996,0.631400861256954,0.333947910079912,"EP300",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","2/81","72/2914",0.601524326504604,0.635867410889815,0.336310268142257,"PIK3CA/PIK3R1",2
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","1/81","33/2914",0.607612774443825,0.638825820507084,0.337874970963347,"MAPK14",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/81","33/2914",0.607612774443825,0.638825820507084,0.337874970963347,"EP300",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/81","33/2914",0.607612774443825,0.638825820507084,0.337874970963347,"AKT1",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","13/81","486/2914",0.608505118715422,0.638825820507084,0.337874970963347,"AKT1/AKT2/AKT3/PAK1/PPP2CA/PPP2CB/PRKACA/RPS6KA1/RPS6KA2/PIK3CA/PIK3R1/MAPK1/MAPK3",13
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/81","34/2914",0.618644834586154,0.647246564952295,0.342328702627883,"CDK1",1
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","1/81","34/2914",0.618644834586154,0.647246564952295,0.342328702627883,"PAK1",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/81","35/2914",0.629370448613418,0.656220723724912,0.347075135125417,"CTNNB1",1
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","1/81","35/2914",0.629370448613418,0.656220723724912,0.347075135125417,"PRKACA",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","2/81","76/2914",0.631318863755794,0.657130878628263,0.347556516045959,"CTNNB1/TCF7L2",2
"R-HSA-73894","R-HSA-73894","DNA Repair","4/81","157/2914",0.644271133237361,0.669472214979639,0.354083848735893,"TP53/EP300/UBE2I/YY1",4
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/81","81/2914",0.666128430399579,0.691009288580888,0.365474806778073,"TP53/UBE2I",2
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/81","39/2914",0.669373239654115,0.693198388862142,0.366632621897972,"EP300",1
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/81","40/2914",0.678688289249947,0.700470514749523,0.370478849217165,"CDK1",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/81","40/2914",0.678688289249947,0.700470514749523,0.370478849217165,"CDK1",1
"R-HSA-162599","R-HSA-162599","Late Phase of HIV Life Cycle","1/81","42/2914",0.69654764357757,0.716482508797803,0.378947592731373,"TBP",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/81","42/2914",0.69654764357757,0.716482508797803,0.378947592731373,"STAT3",1
"R-HSA-422356","R-HSA-422356","Regulation of insulin secretion","1/81","45/2914",0.721513886983953,0.740915941087723,0.391870434859042,"PRKACA",1
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","1/81","48/2914",0.744449340800116,0.763185481927636,0.403648794817442,"UBE2I",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/81","51/2914",0.765517294538606,0.782158974854663,0.413683875063109,"E2F1",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/81","51/2914",0.765517294538606,0.782158974854663,0.413683875063109,"FBXW7",1
"R-HSA-162587","R-HSA-162587","HIV Life Cycle","1/81","53/2914",0.778599828260564,0.794197821481143,0.420051220940151,"TBP",1
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","1/81","59/2914",0.813674132339629,0.828591491432523,0.438242032681169,"UBE2I",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","1/81","63/2914",0.833946567972247,0.847822550800404,0.448413339815185,"UBE2I",1
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","1/81","68/2914",0.856247295865925,0.869048335172891,0.459639656986954,"PAK1",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","4/81","217/2914",0.86539265290927,0.876873815800272,0.463778553623367,"PPP2CA/PPP2CB/PRKACA/MAPK1",4
"R-HSA-5663205","R-HSA-5663205","Infectious disease","2/81","126/2914",0.873750391002098,0.883876637255434,0.46748234583068,"CTNNB1/TBP",2
"R-HSA-162906","R-HSA-162906","HIV Infection","1/81","80/2914",0.898411850091519,0.907321719679203,0.479882449722656,"TBP",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/81","88/2914",0.919468182350412,0.927054553491917,0.490319145356221,"FBXW7",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/81","115/2914",0.963410136164289,0.969758802629952,0.512905422357473,"FBXW7",1
"R-HSA-382551","R-HSA-382551","Transport of small molecules","1/81","121/2914",0.969325982240417,0.974108840705419,0.515206157458116,"PRKACA",1
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","0/81","11/2914",1,1,0.528899991385994,"",0
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","0/81","14/2914",1,1,0.528899991385994,"",0
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","0/81","29/2914",1,1,0.528899991385994,"",0
